BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | ||
Statutory Rules of Northern Ireland |
||
You are here: BAILII >> Databases >> Statutory Rules of Northern Ireland >> The Social Security (Industrial Injuries) (Prescribed Diseases) (Amendment) Regulations (Northern Ireland) 2012 No. 100 URL: http://www.bailii.org/nie/legis/num_reg/2012/nisr_2012100_en_1.html |
[New search] [Printable PDF version] [Help]
Statutory Rules of Northern Ireland
Social Security
Made
7th March 2012
Coming into operation
30th March 2012
The Department for Social Development makes the following Regulations in exercise of the powers conferred by sections 108(2) and 171(1), (3) and (4) of the Social Security Contributions and Benefits (Northern Ireland) Act 1992(1) and now vested in it(2).
It is satisfied of the matters referred to in section 108(2) of that Act.
1. These Regulations may be cited as the Social Security (Industrial Injuries) (Prescribed Diseases) (Amendment) Regulations (Northern Ireland) 2012 and shall come into operation on 30th March 2012.
2. In Part I of Schedule 1 to the Social Security (Industrial Injuries) (Prescribed Diseases) Regulations (Northern Ireland) 1986(3) (list of prescribed diseases and the occupations for which they are prescribed)-
(a)for the entry relating to prescribed disease A4(4) substitute-
"A4. | Task-specific focal dystonia of the hand or forearm. | Prolonged periods of handwriting, typing or other repetitive movements of the fingers, hand or arm.". |
(b)in the second column of the entry relating to prescribed disease A14(5) add-
"Work wholly or mainly fitting or laying carpets or floors (other than concrete floors) for a period of, or periods which amount in aggregate to, 20 years or more.". |
(c)for the entry relating to prescribed disease C3 substitute-
"C3.(a) | Phossy Jaw. | Work involving the use or handling of, or exposure to, white phosphorous. |
C3.(b) | Peripheral polyneuropathy or peripheral polyneuropathy with pyramidal involvement of the central nervous system, caused by organic compounds of phosphorous which inhibit the enzyme neuropathy target esterase. | Work involving the use or handling of, or exposure to, organic compounds of phosphorous.". |
Sealed with the Official Seal of the Department for Social Development on 7th March 2012
(L.S.)
Anne McCleary
A senior officer of the Department for Social Development
(This note is not part of the Regulations)
These Regulations amend the Social Security (Industrial Injuries) (Prescribed Diseases) Regulations (Northern Ireland) 1986 which prescribe diseases for which industrial injuries benefit is payable.
Regulation 2 adds the disease osteoarthritis of the knee, as it relates to carpet fitters and carpet and floor layers, to prescribed disease A14 (osteoarthritis of the knee) and makes amendments to the terms of prescription for prescribed diseases A4 (task-specific focal dystonia) and C3 (poisoning by phosphorous, organic and inorganic phosphorous compounds) in Part I of Schedule 1 to those Regulations.
These Regulations make in relation to Northern Ireland only provision corresponding to provision contained in Regulations made by the Secretary of State for Work and Pensions in relation to Great Britain and accordingly, by virtue of section 149(3) of, and paragraph 7 of Schedule 5A to, the Social Security Administration (Northern Ireland) Act 1992 (c. 8), are not subject to the requirement of section 149(2A) of that Act for prior reference to the Industrial Injuries Advisory Council.
1992 c. 7; section 171(1) was amended by paragraph 5 of Schedule 4 to the Tax Credits Act 2002 (c. 21)
See Article 8(b) of S.R. 1999 No. 481
S.R. 1986 No. 179; relevant amending Regulations are S.R. 2005 No. 37
Prescribed disease A4 was substituted by regulation 2(2) of S.R. 2007 No. 167
Prescribed disease A14 was added by regulation 2 of S.R. 2009 No. 228